Literature DB >> 11160618

The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.

J A Schetz1, D R Sibley.   

Abstract

Most biogenic amine G protein-coupled receptors contain a conserved aspartic acid residue positioned near the intracellular side of the second transmembrane-spanning (TMS) domain that is the primary site of allosteric modulation by sodium ions and pH. Recently, zinc ions and amiloride derivatives were found to allosterically modulate antagonist binding to dopamine receptors. In the current study, the wild-type D4 dopamine receptor showed an 8-fold decrease in zinc affinity in the presence of 120 mM NaCl, but the binding of zinc to the neutral TMS2 D4-D77N mutant was completely sodium-insensitive. In contrast to zinc, methylisobutylamiloride (MIA) binding to the wild-type D4 receptor was virtually unaffected by sodium. In addition, the binding affinity for MIA was essentially unchanged in the presence of an IC(50) concentration of zinc and vice versa. Furthermore, MIA binding affinity was decreased 4-fold for the D4-D77N mutant and increased 30-fold for the TMS3 mutant D4-M107V, even though the binding affinity for zinc was similar to the wild-type D4 background for both mutants. These findings demonstrate for the first time the existence of three distinct sites of allosteric modulation within a G protein-coupled receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160618

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

Review 1.  Modulation of GPCRs by monovalent cations and anions.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-30       Impact factor: 3.000

Review 2.  Allostery at opioid receptors: modulation with small molecule ligands.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

3.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

4.  Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors.

Authors:  Mayako Michino; R Benjamin Free; Trevor B Doyle; David R Sibley; Lei Shi
Journal:  Chem Commun (Camb)       Date:  2015-05-21       Impact factor: 6.222

5.  Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Authors:  Laura H Heitman; Thea Mulder-Krieger; Ronald F Spanjersberg; Jacobien K von Frijtag Drabbe Künzel; Alessandro Dalpiaz; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Sodium binding to hH3R and hH 4R--a molecular modeling study.

Authors:  Hans-Joachim Wittmann; Roland Seifert; Andrea Strasser
Journal:  J Mol Model       Date:  2014-08-07       Impact factor: 1.810

7.  Induced effects of sodium ions on dopaminergic G-protein coupled receptors.

Authors:  Jana Selent; Ferran Sanz; Manuel Pastor; Gianni De Fabritiis
Journal:  PLoS Comput Biol       Date:  2010-08-12       Impact factor: 4.475

8.  D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.

Authors:  Lani S Chun; R Benjamin Free; Trevor B Doyle; Xi-Ping Huang; Michele L Rankin; David R Sibley
Journal:  Mol Pharmacol       Date:  2013-05-16       Impact factor: 4.436

9.  Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor.

Authors:  Zhan-Guo Gao; Soo-Kyung Kim; Ariel S Gross; Aishe Chen; Joshua B Blaustein; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

10.  Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding.

Authors:  Spencer S Ericksen; David F Cummings; Harel Weinstein; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2008-10-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.